Drug recall · December 25, 2024
Dihydroergotamine Mesylate Injection recall
Why: Discoloration
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05
- Lots / codes
Lot #: F9026F01, F9026F02, Exp. Date 12/2025
- Quantity
- 2160 packs/5 ampules per pack = 10,800 ampules
- Company
- Provepharm Inc., Collegeville, PA
- Distribution
- Nationwide within the United States
- Initiated
- November 22, 2024 · Voluntary: Firm initiated
- Classified
- December 16, 2024
- Reported
- December 25, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dihydroergotamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.